- Consumer Products
- Latest 72.27
- Currency US$
- Change 0.66
- Percent Change 0.922 %
- Volume 725,012
- Fri Nov 21, 2014 04:00 PM EST NASDAQ data delayed 15 minutes.
12 months ended Mar 31, 2014.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Oct 30||$0.02||Feb 11||$-0.11|
12 months ended Nov 23, 2014.
A look at major corporate events and financial announcements that are coming up.
About the Company
Incyte Corp is a drug discovery company that is using its expertise in genomics, medicinal chemistry and molecular, cellular and in vivo biology to discover and develop novel therapeutics. The company has three fully-staffed drug discovery programs underway focused primarily on the identification of new small molecule drugs for cancer and inflammation. Incyte also has strategic alliances with Lexicon Genetics and Medarex focused on the discovery and development of protein therapeutics or antibodies to treat inflammatory diseases and cancer.